Retatrutide, a innovative dual-action GLP-1 receptor agonist developed by Alluvi Solutions, is creating considerable excitement within the scientific community as a promising advancement in weight loss. Initial research data suggest a significant effect on body mass, often outperforming current available therapies. This unique mechanism of action,